Press release from PR Newswire
Cyberonics to Participate in Upcoming September Investor Conferences
Monday, September 13, 2010
HOUSTON, Sept. 13 /PRNewswire/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that it will present at two conferences this month.
Dan Moore, President and Chief Executive Officer, will present at the UBS Global Life Sciences Conference in New York on Tuesday, September 21, 2010 at 1:00 PM EDT. UBS will host a webcast of the presentation live and by replay at http://cc.talkpoint.com/ubsx001/092110a_lv/?entity=66_7PVQHBG. The conference webcast replay will be available for 90 days following the conference. The conference webcast can also be accessed at www.cyberonics.com by clicking on the link for this webcast. Access to the webcast is not password protected.
James Reinstein, Vice President, Sales & Marketing and General Manager, International, will present at the Fifth Annual JMP Securities Healthcare Conference in New York on Tuesday, September 28, 2010 at 2:30 PM EDT. There will be no webcast for this conference.
About Cyberonics, Inc. and VNS Therapy®
Cyberonics, Inc. (NASDAQ: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in approximately 70 countries worldwide, and to date more than 60,000 patients have been implanted with the device.
Additional information on Cyberonics and VNS Therapy is available at www.cyberonics.com.
Greg Browne, CFO
100 Cyberonics Blvd.
Houston, TX 77058
Main: (281) 228-7262
Fax: (281) 218-9332
SOURCE Cyberonics, Inc.
For further information: Greg Browne, CFO of Cyberonics, Inc., Main, +1-281-228-7262, Fax, +1-281-218-9332, firstname.lastname@example.org